[Postoperative features in lung cancer patients receiving intraoperative radiotherapy and radiosensitization]

Vopr Onkol. 2006;52(4):414-6.
[Article in Russian]

Abstract

Research Institute of Oncology, Research Center, Russian Academy of Medical Sciences, Siberian Branch, Tomsk. Postoperative course was studied of stage III non-small cell lung cancer (35) treated radically using intraoperative radiotherapy (15Gy) and cisplatin radiosensitization. Postoperative complications were reported in 11.4 +/- 5.4%. Reduction in complication rates was due to the use of a combined treatment complex. There were no postoperative lethalities.

Publication types

  • English Abstract

MeSH terms

  • Adult
  • Aged
  • Chemotherapy, Adjuvant
  • Cisplatin / therapeutic use*
  • Female
  • Humans
  • Intraoperative Care
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / pathology
  • Lung Neoplasms / radiotherapy*
  • Lung Neoplasms / surgery
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Pneumonectomy* / adverse effects
  • Radiation-Sensitizing Agents / therapeutic use*
  • Radiotherapy Dosage
  • Radiotherapy, Adjuvant
  • Treatment Outcome

Substances

  • Radiation-Sensitizing Agents
  • Cisplatin